Fate Therapeutics
FATE
#7647
Rank
C$0.36 B
Marketcap
$3.20
Share price
10.63%
Change (1 day)
-1.11%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$2.94

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.03. In 2022 the company made an earnings per share (EPS) of -$4.06 a decrease over its 2021 EPS that were of -$3.11.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.94-27.72%
2022-$4.0630.49%
2021-$3.117.21%
2020-$2.9045.45%
2019-$2.0019.17%
2018-$1.6717.65%
2017-$1.42-3.77%
2016-$1.48-12.4%
2015-$1.69-3.97%
2014-$1.76-2.09%
2013-$1.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$10.93 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.75-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$12.07 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.33 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.74-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA